In 2023, Sweden led European nations in business expenditure on R&D in human health activities as a percentage of GDP, closely followed by Hungary and Croatia. Spain and Portugal followed with moderate allocations, while Finland, Italy, and Slovakia showed equivalent and notably lower Rates. Expenditure by Malta and Czech Republic remained marginal. Yearly data show Slovakia's highest growth rate at 43.1%, with Portugal and Finland also experiencing significant increases.
Future trends suggest a growing emphasis on health R&D across Europe, with potential increases driven by technological advancements and policy incentives, particularly in nations with historically lower investment levels.
Top countries in Business Expenditure on R&D in Human Health Activities by Country
| # | 10 Countries | Percent of GDP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Sweden | 0.034 | 2023 | +21.43% | View data | |
| 2 | 2 Hungary | 0.031 | 2021 | View data | ||
| 3 | 3 Croatia | 0.026 | 2023 | +44.44% | View data | |
| 4 | 4 Spain | 0.025 | 2021 | View data | ||
| 5 | 5 Portugal | 0.021 | 2023 | +5% | +16% | View data |
| 6 | 6 Finland | 0.018 | 2023 | +20% | +26.76% | View data |
| 7 | 7 Italy | 0.018 | 2023 | +5.88% | +3.71% | View data |
| 8 | 8 Slovakia | 0.018 | 2023 | +12.5% | +43.1% | View data |
| 9 | 9 Malta | 0.003 | 2023 | 0% | View data | |
| 10 | 10 Czech Republic | 0.002 | 2021 | 0% | 0% | View data |
